TY - JOUR TI - LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma AU - Teng, Fei AU - Zhang, Ju-Xiang AU - Chang, Qi-Meng AU - Wu, Xu-Bo AU - Tang, Wei-Guo AU - Wang, Jian-Fa AU - Feng, Jin-Feng AU - Zhang, Zi-Ping AU - Hu, Zhi-Qiu T2 - Journal of Experimental & Clinical Cancer Research AB - Long non-coding RNAs (lncRNAs) are crucial in the invasion, angiogenesis, progression, and metastasis of hepatocellular carcinoma (HCC). The lncRNA MYLK-AS1 promotes the growth and invasion of HCC through the EGFR/HER2-ERK1/2 signaling pathway. However, the clinical significance of MYLK-AS1 in HCC still needs to be further determined. DA - 2020/11/09/ PY - 2020 DO - 10.1186/s13046-020-01739-z DP - BioMed Central VL - 39 IS - 1 SP - 235 J2 - Journal of Experimental & Clinical Cancer Research SN - 1756-9966 UR - https://doi.org/10.1186/s13046-020-01739-z Y2 - 2020/11/23/21:44:09 ER -